title: Therapy-related myelodysplastic syndromes.
abstract: This article summarizes the clinical aspects, cytogenetics, and initiating agents associated with therapy-related myelodysplastic syndromes. Details regarding associated chemotherapeutic agents and ionizing radiation are discussed and therapeutic considerations are presented.
authors.affiliation: Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
authors.forename: B
authors.initials: B
authors.lastname: Rosenbloom
authors.forename: R
authors.initials: R
authors.lastname: Schreck
authors.forename: H P
authors.initials: HP
authors.lastname: Koeffler
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000139:chemically induced / Q000209:etiology* / Q000235:genetics; D011878:Radiotherapy / Q000009:adverse effects*; D012307:Risk Factors
chemical_list: D000970:Antineoplastic Agents